7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
7-days of FREE Audio papers, translation & more with Prime
7-days of FREE Prime access
https://doi.org/10.25236/fmsr.2023.050411
Copy DOIPublication Date: Jan 1, 2023 |
Objective: To analyze the expression and significance of TMEFF2 gene methylation in bladder cancer. Methods: The promoter region methylation level of the MEFF 2 gene was analyzed by applying the expression database and gene methylation.64 urine samples were detected by demethylated drug-nitrogen-2 deoxycytidine to observe the changes of cell invasion and apoptotic valence, and its application value in bladder cancer was analyzed by applying high expression of TMEFF2 gene. Results: Drug treatment of bladder cancer cells showed that the appreciation and migration of bladder cancer were inhibited, but the number of apoptosis increased. Conclusion: TMEFF2 gene promoter methylation is one of the markers of bladder cancer and plays an important role in the diagnosis of bladder cancer.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.